RxDoctor Payments Data

Jeffrey Grass, MD

Radiation Oncology · Fairfield, OHNPI 1275574535

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,866 of the $5,199 with a category attached, or 74.4%. 22 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 31.2% of the total. Reporting peaked in 2024 at $2,582 and has fallen 70.7% since, to $757 in 2025.

$5,199in general payments, 2019–2025

Across 93 payments — averaging $55.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$2K
  • Janssen Scientific Affairs, LLC$674
  • Bayer$435
  • Dendreon Pharmaceuticals LLC$357
  • Novartis$248
  • Boston Scientific$237
  • plus $2K from 16 others

What the payments were for

  • Travel & lodging$1,33326%
  • Food & beverage$3,86674%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,199 in reported general payments places this provider in the 85th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$1,358,204
Medicare patients
469
Services billed
3,109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl108$954
Dexamethasone20$227

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Fairfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →